Josep Lluís Parra-Palau

Author

Also Known As

J L Parra-Palau, J. Parra-Palau, J.L. Parra-Palau, Josep L. Parra-Palau, Josep L. Parra‐Palau, Josep Lluis Parra-Palau, Josep Lluís Parra-Palau, Josep L. PARRA-PALAU, Perou, Charles M.

Publications

787

Citations

H-Index

Concepts

All Affiliations

Universitat Autònoma de Barcelona Hebron University Institució Catalana de Recerca i Estudis Avançats Vall d'Hebron Institute of Oncology Institut Gustave Roussy

About

Josep Lluís Parra-Palau is an author at Universitat Autònoma de Barcelona specializing in cell signaling, cell biology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	247
2	Cell Biology	3	3	247
3	Natural Sciences	1	1	12
4	Cellular Physiology	1	1	12
5	Pathology	1	1	54

Josep Lluís Parra-Palau

Publications

525

Citations

H-Index

Page 1

	Year	Citations
A Naturally Occurring HER2 Carboxy-Terminal Fragment Promotes Mammary Tumor Growth and Metastasis Kim Pedersen, Pier-Davide Angelini, Sirle Laos, Molecular and Cellular Biology Breast OncologyMammary GlandsCell SignalingMedicineCancer Growth	2009	181
Constitutive HER2 Signaling Promotes Breast Cancer Metastasis through Cellular Senescence Pier Davide Angelini, Mariano F. Zacarías Fluck, Kim Pedersen, Cancer Research	2013	103
Effect of p95HER2/611CTF on the Response to Trastuzumab and Chemotherapy Josep Lluís Parra-Palau, Beatriz Morancho, Vicente Peg, JNCI Journal of the National Cancer Institute	2014	54
A Major Role of p95/611-CTF, a Carboxy-Terminal Fragment of HER2, in the Down-modulation of the Estrogen Receptor in HER2-Positive Breast Cancers Josep Lluís Parra-Palau, Kim Pedersen, Vicente Peg, Cancer Research Breast OncologyEndocrine-related CancerHer2-positive Breast CancersEr PositivityMedicine	2010	54
Clinical activity of <scp>CC‐90011</scp>, an oral, potent, and reversible <scp>LSD1</scp> inhibitor, in advanced malignancies Antoine Hollebecque, Stefania Salvagni, Ruth Plummer, Cancer	2022	45
Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma Antoine Hollebecque, Stefania Salvagni, Ruth Plummer, Clinical Cancer Research	2020	42
HER2 Carboxyl-terminal Fragments Regulate Cell Migration and Cortactin Phosphorylation Jesús Garcı́a-Castillo, Kim Pedersen, Pierdavide Angelini, Journal of Biological Chemistry	2009	34
The <i>Drosophila</i> protein kinase LK6 is regulated by ERK and phosphorylates the eukaryotic initiation factor eIF4E <i>in vivo</i> Josep Lluís Parra-Palau, Gert C. Scheper, Daniel E. HARPER, Biochemical Journal Molecular RegulationP38 MapkCellular PhysiologyTranscriptional RegulationSignaling Pathway	2005	12

Page 1